We’re excited to ring in 2022 by announcing that we’ve acquired Ireland-based BioPharma Engineering, a life sciences engineering consulting firm.
As we focus on enhancing our ability to serve our global clients everywhere through industry specialization, expanded account management, and geographic expansion, our partnership with BPE will deepen our Life Sciences expertise.
BPE, which becomes BPE, a Unispace Life Sciences company, offers bespoke engineering design for the pharmaceutical and life sciences sectors, concentrating specifically on delivering mid-range capital value projects. BPE works with seven of the world’s top 10 pharmaceutical companies, as well as other leading industry establishments, and has a reputation as a top-tier strategist to companies in the space. Key clients include Eli Lilly, Regeneron, Viatris, and GE Healthcare.
The acquisition is an important next step in our global growth strategy and follows on from the attainment of experiential design firm Downstream, an expert in transforming flagship retail-, sports- and educational- venues into digital and physical experiences, in October 2021.
Deepening our offering for life sciences customers
Unispace has deep expertise in and a strong track record of delivering office space for life science customers, including work with clients Abbott, Galderma, Smith and Nephew, Takeda, and Boston Scientific. The merger with BPE will allow us to support clients with a much deeper level of expertise on highly complex life sciences projects including lab, research & development and manufacturing facilities. John O’Reilly, managing director of BioPharma Engineering will become our global lead for Unispace Life Sciences.
Steve Quick, Global CEO, Unispace said:
“The life sciences industry delivers innovation that transforms peoples’ lives for the better. The sector has experienced huge investment in recent years, which is driving up demand for world class facilities and the best talent. We are excited to welcome BPE to our team and bring our shared expertise together, allowing us to better support our clients with deeper expertise in more locations across the globe.”
John O’Reilly, Global Lead, Unispace Life Sciences said:
“We are excited to embark on this new journey with Unispace. The partnership aligns well with our own growth plans, we share similar values, and our priority is our people.
The life sciences sector is evolving at a record pace and key to success is outstanding facilities, which supports innovation and can attract the best talent. With our combined expertise we are well placed to support pharmaceutical clients across the globe to excel.”